恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
恒瑞医药(600276) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入2,318,808.191,576,119.36720,561.112,798,460.532,018,930.38
营业收入2,318,808.191,576,119.36720,561.112,798,460.532,018,930.38
二、营业总成本1,691,564.981,090,017.40513,469.062,100,800.051,508,997.92
营业成本319,544.12211,496.22106,866.25384,817.74283,318.27
营业税金及附加20,062.1512,390.706,005.9325,788.4017,241.50
销售费用678,048.46438,930.55196,722.27833,606.90610,928.78
管理费用212,684.97128,510.2358,608.20255,568.68187,411.17
财务费用-33,306.58-24,103.65-8,054.32-57,273.22-44,788.83
研发费用494,531.86322,793.35153,320.73658,291.55454,887.03
资产减值损失----------
公允价值变动收益9,780.0411,126.39-1,311.2710,863.08952.97
投资收益-4,082.32-2,215.79-681.85427.94-3,142.04
其中:对联营企业和合营企业的投资收益-5,549.96-4,146.67-2,484.79-2,158.08-5,422.76
汇兑收益----------
三、营业利润662,451.24515,889.27208,598.09749,063.20534,529.05
加:营业外收入423.31231.7462.351,044.60579.09
减:营业外支出21,673.7711,027.591,100.0733,138.8126,434.13
其中:非流动资产处置损失----------
四、利润总额641,200.78505,093.42207,560.37716,969.00508,674.02
减:所得税费用65,177.2659,626.3619,916.1883,269.5347,041.00
五、净利润576,023.52445,467.07187,644.20633,699.46461,633.02
归属于母公司所有者的净利润575,116.95445,010.64187,405.55633,652.70461,957.59
少数股东损益906.56456.43238.6446.76-324.57
六、每股收益
基本每股收益(元/股)0.89000.70000.30001.00000.7300
稀释每股收益(元/股)0.89000.70000.30001.00000.7300
七、其他综合收益2,046.712,615.16234.68-62.40-1,263.10
八、综合收益总额578,070.23448,082.23187,878.88633,637.06460,369.92
归属于母公司所有者的综合收益总额577,085.74447,655.04187,650.22633,417.49460,807.66
归属于少数股东的综合收益总额984.49427.19228.65219.58-437.74
下载全部历史数据到excel中 返回页顶